Express News | IDEAYA Biosciences Inc : Leerink Partners Cuts Target Price to $48 From $50
Express News | IDEAYA Biosciences Inc : Jefferies Raises Target Price to $60 From $52
Express News | IDEAYA Biosciences Inc : Wedbush Cuts Target Price to $54 From $56
Wedbush Cuts Price Target on IDEAYA Biosciences to $54 From $56, Maintains Outperform Rating
Industry Analysts Just Made A Meaningful Upgrade To Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Revenue Forecasts
IDEAYA Biosciences Is Maintained at Overweight by JP Morgan
JPMorgan Raises Price Target on IDEAYA Biosciences to $69 From $65, Maintains Overweight Rating
J.P. Morgan Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $69
Express News | IDEAYA Biosciences Inc : Mizuho Raises Target Price to $55 From $50
Mizuho Securities Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Raises Target Price to $55
Upgraded Outlook on IDEAYA Biosciences Amid Promising Phase 2 Trial Results for IDE397
Express News | IDEAYA Biosciences Inc : JP Morgan Raises Target Price to $69 From $65
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
IDEAYA Biosciences Price Target Raised to $61.00/Share From $53.00 by RBC Capital
Express News | RBC Capital Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $61
IDEAYA Biosciences Analyst Ratings
Express News | IDEAYA Biosciences Inc : RBC Raises Target Price to $61 From $53
RBC Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Raises Target Price to $61
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
No Data